Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy in Earlier Stage Breast Cancer

NCT01682499 is registered in ClinicalTrials.gov with Beth Israel Medical Center as lead sponsor.

NCT NCT01682499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01682499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy in Earlier Stage Breast Cancer
Lead sponsor
Beth Israel Medical Center
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2012
Completion date
August 31, 2014
Enrollment
50 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

paclitaxel-induced neuropathy